EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward

Edwin H Kim iD, J Andrew Bird iD, Helen A Brough, David M Fleischer, Stacie M Jones, Ildiko Kun, Wayne Shreffler, Claire Van Eenwyk, Brian P Vickery iD, Julie Wang, Alexandra F Santos iD

Allergy · 23.03.2026

DOI: 10.1111/all.70304 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Allergy, online erschienen am 23.03.2026. Verfasst von Edwin H Kim und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The oral food challenge (OFC) has long been the reference standard for food allergy diagnosis, as well as to confirm natural development of oral tolerance. The utilization of OFCs has significantly broadened from its role in defining disease to defining participant eligibility, individual allergen reactivity thresholds and treatment outcomes metrics in clinical trials. Adopting OFCs as the sole primary metric to gauge the efficacy of an investigational drug can pose some limitations, such as: creating a barrier to recruitment of representative populations; excluding a vast number of allergic individuals through arbitrary reaction criteria; increasing cost and burden for participants, investigators, institutions, and sponsors; and, most importantly, adding additional risks and/or unpleasant experiences to study participants. A panel of expert allergists was convened by Parexel to discuss the current and future landscape for conducting clinical trials, the role of the OFC and immunologic biomarkers in the context of food allergy clinical trials, and potential innovations for advancing therapeutic development.

Schlagwörter

Stichwörter der Autor:innen

anti‐IgEbasophil activation testbiologicalsdouble‐blind placebo‐controlled food challengefood allergyimmunotherapyoral food challenge

Autor:innen und Institutionen

  • Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
  • Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Department of Women and Children's Health (Pediatric Allergy), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, King's College London, London, UK.
  • Children's Allergy Service, Evelina London Children's Hospital, Guy's and St Thomas' Hospital, London, UK.
  • Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colorado, USA.

ORCID-Profile: Edwin H Kim, J Andrew Bird, Brian P Vickery, Alexandra F Santos

Zitieren

APA

Kim, E. H., Bird, J. A., Brough, H. A., Fleischer, D. M., Jones, S. M., Kun, I., Shreffler, W., Van Eenwyk, C., Vickery, B. P., Wang, J., & Santos, A. F. (2026). Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward. Allergy. https://doi.org/10.1111/all.70304

Vancouver

Kim EH, Bird JA, Brough HA, Fleischer DM, Jones SM, Kun I, et al. Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward. Allergy. 2026. doi:10.1111/all.70304

BibTeX
@article{Kim2026,
  author = {Kim, Edwin H and Bird, J Andrew and Brough, Helen A and Fleischer, David M and Jones, Stacie M and Kun, Ildiko and Shreffler, Wayne and Van Eenwyk, Claire and Vickery, Brian P and Wang, Julie and Santos, Alexandra F},
  title = {Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward},
  journal = {Allergy},
  year = {2026},
  doi = {10.1111/all.70304}
}
Kostenlos starten →